Vontobel Holding »

Black Diamond Therapeutics shares owned by Vontobel Holding

Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Vontobel Holding from 13F filings

Historical chart of Vontobel Holding investment in Black Diamond Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Black Diamond Therapeutics held by Vontobel Holding consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Black Diamond Therapeutics by Vontobel Holding

Quarter filed Position value Share count Share price at filing
2026-06-30 $19k 10k 1.85
2024-09-30 $68k 16k 4.35

More positions owned by Vontobel Holding

NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Microsoft Corporation (MSFT)
Ubs Group SHS (UBS)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Micron Technology (MU)
Alphabet Cap Stk Cl C (GOOG)
Waste Management (WM)
Coca-Cola Company (KO)
Apple (AAPL)
Rb Global (RBA)
Mastercard Incorporated Cl A (MA)
Logitech Intl S A SHS (LOGI)
Alcon Ord Shs (ALC)

View all positions for Vontobel Holding

Top funds holding Black Diamond Therapeutics

NEA Management Company
BlackRock
Acadian Asset Management
Vanguard Capital Management
Renaissance Technologies
Defilade Capital Management
Dimensional Fund Advisors
Geode Capital Management
Connor, Clark & Lunn Investment Management
AWM Investment Company
Marshall Wace
Bridgeway Capital Management
FMR
Balyasny Asset Management
Bank of America Corporation

View all funds holding Black Diamond Therapeutics